SCHEMBL7049754

SCHEMBL7049754

O=C(Nc1ccccc1S(=O)(=O)NC(=O)c1ccc(F)cc1F)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
NR1H4 Q96RI1 1/20 0.48
SMPD1 P17405 2/20 0.48
NR4A2 P43354 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
TSHR P16473 1/20 0.48
BCL2L1 Q07817 2/20 0.48
MCL1 Q07820 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CASP3 P42574 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
HDAC2 Q92769 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052824 0.88 SMPD1 (0.62) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7076463 0.87 SMPD1 (0.52) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7045604 0.87 SMPD1 (0.61) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7083454 0.86 SMPD1 (0.54) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7082518 0.86 SMPD1 (0.54) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7081001 0.86 HDAC1 (0.56) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7044608 0.86 SMPD1 (0.53) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7077931 0.85 HDAC1 (0.54) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7076910 0.84 HDAC1 (0.59) HDAC1HDAC8HDAC6NR1H4SMPD1
SCHEMBL7045371 0.83 KMT2A (0.62) HDAC1HDAC8HDAC6NR1H4SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN HDAC1 271/4885HDAC8 1064/4885HDAC6 399/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 HDAC1 305/4885HDAC8 293/4885HDAC6 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.